Search for Clinical Trial Results

Malignant Mixed Mullerian Tumor - 25 Studies Found
Status | Study |
Completed |
Study Name: Paclitaxel and Carboplatin in Women With Malignant Mixed Mullerian Tumors (MMMT) of the Uterus Condition: Mixed Tumor, Mullerian Date: 2007-07-16 Interventions:
|
Completed |
Study Name: Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma Condition: Uterine Carcinosarcoma Date: 2008-05-28 Interventions:
|
Not yet recruiting |
Study Name: Trial On Trabectedin In The Treatment Of Advanced Uterine And Ovarian Carcinosarcoma (CS)_MITO 26 Condition:
|
Not yet recruiting |
Study Name: Pazopanib vs. Pazopanib Plus Gemcitabine in Patients With Relapsed or Metastatic Uterine Leiomyosarcomas or Uterine Carcinosarcomas: a Multi-center, Randomized Phase-II Clinical Trial of the NOGGO and AGO - PazoDoble - Condition: Relapsed or Metastatic Uterine Leiomyosarcomas or Carcinosarcomas Date: 2014-05-05 Interventions:
|
Completed |
Study Name: Oxaliplatin and Gemcitabine Followed by Radiation Therapy in the Management of Mixed Mullerian Tumors of the Uterus Condition: Mixed Mullerian Tumors of the Uterus Date: 2007-05-17 Interventions:
|
Completed |
Study Name: Thalidomide in Treating Patients With Recurrent or Persistent Carcinosarcoma of the Uterus Condition:
Date: 2001-10-11 Interventions: |
Completed |
Study Name: Pazopanib Hydrochloride in Treating Patients With Recurrent or Persistent Uterine Cancer Condition:
Date: 2010-11-23 Interventions: Drug: Pazopanib Hydrochloride Given PO Other Names: |
Active, not recruiting |
Study Name: Ixabepilone in Treating Patients With Recurrent or Persistent Uterine Cancer Condition:
Date: 2010-07-22 Interventions:
|
Terminated |
Study Name: Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus Condition:
Date: 2010-02-02 Interventions: Drug: temsirolimus Given IV Other Names: |
Completed |
Study Name: Gemcitabine and Docetaxel in Treating Patients With Recurrent or Persistent Uterine Cancer Condition:
Date: 2005-06-13 Interventions: |